VOR BIOPHARMA INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • January 15th, 2021 • Vor Biopharma Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJanuary 15th, 2021 Company Industry JurisdictionThis Indemnification Agreement (this “Agreement”) is dated as of [ ], 20[ ], and is between Vor Biopharma Inc., a Delaware corporation (the “Company”), and [ ] (“Indemnitee”).
100 CAMBRIDGEPARK DRIVE CAMBRIDGE, MASSACHUSETTS LEASE Between PPF OFF 100 CAMBRIDGE PARK DRIVE, LLC, a Delaware limited liability company (“LANDLORD”) AND VOR BIOPHARMA, INC., a Delaware corporation (“TENANT”) dated as of December 17, 2019Lease • January 15th, 2021 • Vor Biopharma Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJanuary 15th, 2021 Company Industry JurisdictionThis Lease Agreement (this “Lease”) is made and entered into as of the 17th day of December, 2019 (the “Effective Date”), by and between PPF OFF 100 CAMBRIDGE PARK DRIVE, LLC, a Delaware limited liability company (“Landlord”) and VOR BIOPHARMA, INC., a Delaware corporation (“Tenant”).
Portions of this agreement (indicated by “[***]”) have been omitted as the Registrant has determined that: (i) the omitted information is not material; and (ii) the omitted information is the type that the Registrant treats as private or confidential....Patent License Agreement • January 15th, 2021 • Vor Biopharma Inc. • Biological products, (no disgnostic substances) • District of Columbia
Contract Type FiledJanuary 15th, 2021 Company Industry JurisdictionThis Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Benchmarks and Performance), Appendix E (Commercial Development Plan), Appendix F (Example Royalty Report), and Appendix G (Royalty Payment Options).